Navigation Links
Netsmart Technologies Names Michael Valentine as Chief Executive Officer
Date:5/9/2011

GREAT RIVER, N.Y., May 9, 2011 /PRNewswire/ -- Netsmart Technologies, Inc., a leading provider of software and services for health and human services organizations, today announced that Michael Valentine has been named as the company's chief executive officer. Valentine will join Netsmart from Cerner Corporation, where he served as executive vice president and chief operating officer. He will succeed James Conway, who is retiring after 15 years as Netsmart CEO. Conway will play an active role in the leadership transition.

"Mike's background in health information technology will be valuable as Netsmart helps its clients address key emerging trends such as integration with primary care, certification, interoperability and increasing consumer involvement in the care process," said Mark Hanson, chairman of Netsmart and managing director of Genstar Capital, Netsmart's investment partner. "This transition process has been underway for the past year, and we are pleased that Mike will be joining Netsmart to build on the strong foundation of Jim Conway's leadership that has made Netsmart a solid, stable company, well-positioned for long-term growth and success. We thank Jim for his years of leadership and wish him the best in his well-deserved retirement!"

In his most recent role at Cerner, Valentine was responsible for all global operations, including sales, consulting, technology, solution direction and support for Cerner's worldwide operations. His transition from that role will be completed on May 13.

"At the heart of any successful company are strong, trusted client relationships built on a track record of proven execution," said Valentine. "As the market leader, Netsmart is in the unique position of being able to 'lead' with the best solutions through a commitment to innovation; 'lead' with the best service through the use of proven tools and methods; and 'lead' our clients through an unprecedented environment of regulatory and reimbursement change. I'm excited to have the opportunity with Netsmart to set a new bar not only for health and human services' largest collaborative client community, but for the broader healthcare market as well."

About Netsmart Technologies

Netsmart Technologies is an established, leading supplier of software-as-a service (SaaS) and internally-installed software solutions for health and human services providers. More than 18,000 client organizations, including 350,000 care providers and more than 40 state systems, use Netsmart products to help improve the quality of life for millions of people each year.

Netsmart clients include mental health and substance abuse treatment agencies, psychiatric hospitals, private and group mental health practices, public health departments, vital records offices, and managed care organizations. Netsmart's products are full-featured information systems that operate on a variety of operating systems, hardware platforms, and mobile devices, and offer unlimited scalability.

Netsmart provides the solutions and expertise that help its clients meet all the criteria for Meaningful Use of an Electronic Health Record (EHR) under the American Recovery and Reinvestment Act (ARRA) of 2009. These include a Complete ARRA-Certified EHR and associated solutions, including Netsmart OrderConnect™ for e-prescribing and order entry, Netsmart CareConnect™ that enables the sharing of clinical information with labs and other providers, and the Netsmart ConsumerConnect™ Web portal to provide secure and private consumer access to their care information. Netsmart clients can utilize Netsmart solutions to meet all Stage 1 Meaningful Use criteria, avoiding the costly and time-consuming process of integrating solutions from multiple vendors.

For information about Netsmart Technologies' full range of solutions for health and human services organizations, visit www.ntst.com or call 1-800-472-5509.

Avatar 2011, the CMHC/MIS 4.2 EHR Module and the Insight 7.0 EHR Module are 2011/2012 compliant and have been certified by the Drummond Group, an ONC-ATCB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.

Netsmart OrderConnect, Netsmart CareConnect and Netsmart ConsumerConnect are trademarks of Netsmart Technologies, Inc.


'/>"/>
SOURCE Netsmart Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System
2. Netsmart University Announces Partner Referral Agreement With New York Association of Alcohol and Substance Abuse Providers
3. Netsmart Technologies Introduces Netsmart Customer Innovation Award to Recognize Outstanding Use of Technology to Impact Quality of Care
4. Netsmart Technologies Selected by Douglas Gardens Community Mental Health to Provide Behavioral Health Software Solution
5. Netsmart Announces My Avatar at National Council for Community Behavioral Healthcare Annual Conference
6. Netsmart Technologies and Genstar Capital Announce Investor Partnership
7. Netsmart Technologies to Host Valuable Meaningful Use Web Seminars
8. Former Cerner Chief Operating Officer Joins Netsmart Technologies Board of Directors
9. Netsmart Technologies CMHC/MIS Behavioral Health Software Passes ARRA Certification Tests
10. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
11. RainDance Technologies Appoints Olex Vice President, System Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... February 17, 2017 According ... by Product (Consumables, Service), Type (Safety, Efficacy, Validation), ... Drug Discovery and Development, Disease-Risk) - Global Forecast ... projected to reach USD 53.34 Billion by 2021 ... a CAGR of 13.8% during the forecast period ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
Breaking Biology Technology:
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):